Emergence of resistant variants detected by ultra‐deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis <scp>C</scp> virus genotype 1Koji Kosaka, Kazuaki Chayama, Michio Imamura et al.|Journal of Viral Hepatitis|2014Cited by 34
Non‐invasive assessment of liver steatosis in non‐alcoholic fatty liver diseaseHiromi Kan, Kazuaki Chayama, Yuki Kimura et al.|Hepatology Research|2014Cited by 29
Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinomaYoshio Katamura, Kazuaki Chayama, Hiroshi Aikata et al.|Hepatology Research|2010Cited by 25
Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis CReona Morio, Kazuaki Chayama, Michio Imamura et al.|Journal of Gastroenterology|2016Cited by 20
Ultradeep Sequencing Study of Chronic Hepatitis C Virus Genotype 1 Infection in Patients Treated with Daclatasvir, Peginterferon, and RibavirinEisuke Murakami, Kazuaki Chayama, Shoichi Takahashi et al.|Antimicrobial Agents and Chemotherapy|2014Cited by 18